OTCMKTS:BIOTU Biotech Acquisition (BIOTU) Stock Price, News & Analysis $10.14 -0.84 (-7.65%) (As of 02/2/2023) Add Compare Share Share Stock Analysis Stock Analysis About Biotech Acquisition Stock (OTCMKTS:BIOTU) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Biotech Acquisition alerts:Sign Up Key Stats Today's Range$10.14▼$10.1750-Day Range$10.14▼$10.1452-Week Range$8.73▼$11.11Volume1,300 shsAverage Volume4,444 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewBiotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.Read More… Receive BIOTU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biotech Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address BIOTU Stock News HeadlinesSan Antonio biotech company looks to expand in 2025December 20, 2024 | bizjournals.comRockville biotech GlycoMimetics to be taken privateOctober 29, 2024 | bizjournals.comURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most explosive phase of the cycle.January 2, 2025 | Crypto Swap Profits (Ad)Biotech Septerna aims to raise up to $186 million in US IPOOctober 22, 2024 | reuters.com2 Biotech Stocks to Buy Hand Over Fist in OctoberOctober 9, 2024 | fool.comBioMed Realty CEO sees light amid biotech's dark timesSeptember 3, 2024 | bizjournals.comThe 12 biggest take-private PE acquisitions so far this year in techAugust 25, 2024 | techcrunch.comInnovationRx: Healthcare And Biotech Startups Dominated Venture Capital In JulyAugust 7, 2024 | forbes.comSee More Headlines BIOTU Stock Analysis - Frequently Asked Questions How have BIOTU shares performed this year? Biotech Acquisition's stock was trading at $10.14 at the start of the year. Since then, BIOTU shares have increased by 0.0% and is now trading at $10.14. View the best growth stocks for 2025 here. How do I buy shares of Biotech Acquisition? Shares of BIOTU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorFinancial Services Industry Shell Companies Sub-IndustryTrading Current SymbolOTCMKTS:BIOTU CUSIPN/A CIK1825413 WebN/A Phone(858) 692-0539FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (OTCMKTS:BIOTU) was last updated on 1/2/2025 by MarketBeat.com Staff From Our Partners3 CENT Crypto to Explode December 16th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe Next Big Thing in AI: Musk’s Secret SupplierWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredApple feeling the heat from NvidiaNvidia has moved on to the next frontier of AI it intends to dominate. And we believe the three companies p...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotech Acquisition Please log in to your account or sign up in order to add this asset to your watchlist. Share Biotech Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
